Despite its solid theoretical foundations, sophisticated conceptual models, and ability to generate findings generalizable to community populations, epidemiology’s potential for influencing advances in our understanding and treatment of substance use and other psychiatric disorders remains underused. Research on the etiology of psychiatric disorders tends to be guided by biologically based approaches, such as neuroimaging, animal models, and human organoids, rather than by population-based science; workforce distribution and availability of services seldom match estimates of need; preventive interventions are often based on theoretical models from prevention science, rather than from epidemiologic findings; and policy development rarely includes a process of systematic incorporation of epidemiologic evidence.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Blanco C, Lopez MF, Goldstein AB. User-Centered Psychiatric Epidemiology. JAMA Psychiatry. Published online June 10, 2020. doi:10.1001/jamapsychiatry.2020.1361
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: